MAR 11, 2019 09:12 PM PDT

PARP Inhibitors Boost Immune Efficacy

WRITTEN BY: Nouran Amin

In a recent research study, precision cancer drugs called PARP inhibitors are previously known to boost the immune system were found to spark a powerful immune response when used against cancer cells with weaknesses in DNA repair.

Image: Purple lung cancer cells. Credit: Anne Weston, Francis Crick Institute. Licence: CC BY-NC 4.0

"The findings of this study substantially change our understanding of how PARP inhibitors work. We now know that they not only kill tumors by damaging their DNA, but also by attracting immune cells to attack them -- acting as a sort of double-pronged attack. Immunotherapy is a genuinely brilliant cancer treatment but generally only for the 10 to 20 percent of people who respond to it. Finding the tumour is half of the battle in immunotherapy so by attracting the immune cells to the tumour, PARP inhibitors could enable the immunotherapy drug to target their attack,” says Chris Lord, Professor of Cancer Genomics at The Institute of Cancer Research in London.

Learn more:

Findings of the study were published in the Journal of Clinical Investigation and changes the current understanding on PARP inhibitors and their potential role in cancer treatments alongside immunotherapies. Particularly, certain PARP inhibitors, like olaparib, block a mechanism that cells use to repair DNA.

"Our study found that PARP inhibitors enlist immune cells to aid in the killing of cancer cells. This provides a rationale for using PARP inhibitors alongside immunotherapies to further stimulate the immune response to cancer cells with DNA repair defects and enhance the therapeutic benefit of the treatment. This will be evaluated in a clinical trial of lung, prostate and bladder cancers, which is starting later this year,” says study co-leader Dr. Sophie Postel-Vinay, Clinician Scientist and Medical Oncologist at Gustave Roussy, France, and The Institute of Cancer Research.

Source: The Institute of Cancer Research

 

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 14, 2019
Drug Discovery & Development
DEC 14, 2019
Genital Herpes Vaccine Works in Rodents
A recent vaccine was developed by scientists at Perelman School of Medicine at the University of Pennsylvania that protects against genital herpes. The vac...
DEC 14, 2019
Drug Discovery & Development
DEC 14, 2019
Developing Animal-Free Neurotoxin Testing
The need to assess a group of deadly neurotoxins without turning to animal-testing may soon be a possibility. A new animal-free testing technique was recen...
DEC 14, 2019
Drug Discovery & Development
DEC 14, 2019
Possible New Drug Targets for Glioblastoma
Scientists at Karolinska Institutet in Sweden were able to pinpoint 10 tumor-specific potential drug targets for the fatal and incurable brain cancer, glio...
DEC 14, 2019
Drug Discovery & Development
DEC 14, 2019
Antibiotics from the Sea?
Many of the clinically relevant antibiotics are sourced from natural substances, produced by bacteria. But because of the growing threat of antibiotic resi...
DEC 14, 2019
Drug Discovery & Development
DEC 14, 2019
Drug Seeks To Target Treatment-Resistant Epilepsy
Ever imagined a world where you cannot shower alone, drive by yourself, and even go to work in fear of having the next seizure that can incapacitate you? U...
DEC 14, 2019
Drug Discovery & Development
DEC 14, 2019
Could the diabetic drug 'metformin' extend a healthy lifespan?
The most commonly prescribed diabetic medication for the Type 2 condition is ‘Metformin’—a drug with a mysterious mechanism of action but...
Loading Comments...